Capecitabine Market, By Drug Type (Generic and Branded), By Indication, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2034
REPORT HIGHLIGHT
Capecitabine Market size was valued at USD 415.9 Million in 2023, expanding at a CAGR of 5.50% from 2024 to 2032.
Capecitabine is an oral chemotherapy medication, which is used to treat a number of malignancies, such as those of the breast, colon, and rectal region. It is a member of the antimetabolite medication class, which inhibits the development and transmission of cancer cells. Since capecitabine is a prodrug, the body transforms it into 5-fluorouracil (5-FU), which is its active form. After being transformed, 5-FU stops cancer cells from making DNA and RNA, which eventually kills the cells. Capecitabine, which is typically given as pills, is taken orally as opposed to intravenously as conventional chemotherapy medications. The increase in the older population, the rise in cancer prevalence, and the intense research and development efforts to assess novel pharmacological uses of capecitabine are the main factors propelling the market\'s expansion. Additionally, the market is rising due to factors like the expansion of new cancer institutions, increased expenditure in cancer research, and others that are driving up demand for capecitabine. Furthermore, the market will rise even more during the projection period due to the growing development of new capecitabine product categories.
Capecitabine Market- Market Dynamics
Rising Incidence of Cancer
It is often necessary for the cancer cells to produce and fix DNA. As a result, cancer spreads to other body parts. In order to stop cancer cells from creating and repairing DNA, capecitabine must be used. One of the main factors propelling the use of capecitabine is the rising incidence of cancer, including lung, breast, and other forms, as well as the growing need for pharmaceutical research and development (R&D) for cancer therapy. For instance, the Global Cancer Observatory recently released data showing that 19,292,789 new cases of cancer were reported worldwide in 2020. With 11.7% of all cases, breast cancer was the most frequent type of cancer in 2020. Lung cancer came in second with 11.4%, colorectum cancer with 10%, prostate cancer with 7.3%, and stomach cancer with 5.6%. In order to stop cancer from spreading to important body parts, capecitabine is becoming more and more necessary as the number of cancer cases worldwide rises. Consequently, this is contributing to the expansion of the market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CAPECITABINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Teva Pharmaceutical Industries Ltd.(Israel)
F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Pfizer Inc. (US.)
Sanofi (France)
Bayer AG (Germany)
Lilly (US.)
Sun Pharmaceutical Industries Ltd. (India)
GSK plc (UK.)
Novartis AG (Switzerland)
Merck & Co., Inc. (US.)
Alkem Labs Ltd (India)
Aurobindo Pharma (India)
Lupin (India)
Others
GLOBAL CAPECITABINE MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
Generic
Branded
GLOBAL CAPECITABINE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032
Breast Cancer
Pancreatic Cancer
Colorectal Cancer
Gastric Cancer
Others
GLOBAL CAPECITABINE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Hospitals
Specialty Clinics
Homecare
Others
GLOBAL CAPECITABINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The US.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Capecitabine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Capecitabine Market Snippet by Drug Type
2.1.2. Capecitabine Market Snippet by Indication
2.1.3. Capecitabine Market Snippet by End-user
2.1.4. Capecitabine Market Snippet by Country
2.1.5. Capecitabine Market Snippet by Region
2.2. Competitive Insights
3. Capecitabine Key Market Trends
3.1. Capecitabine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Capecitabine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Capecitabine Market Opportunities
3.4. Capecitabine Market Future Trends
4. Capecitabine Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Capecitabine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Capecitabine Market Landscape
6.1. Capecitabine Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Capecitabine Market – By Drug Type
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
7.1.2. Generic
7.1.3. Branded
8. Capecitabine Market – By Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
8.1.2. Breast Cancer
8.1.3. Pancreatic Cancer
8.1.4. Colorectal Cancer
8.1.5. Gastric Cancer
8.1.6. Others
9. Capecitabine Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
9.1.2. Hospitals
9.1.3. Specialty Clinics
9.1.4. Homecare
9.1.5. Others
10. Capecitabine Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Capecitabine Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Capecitabine Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Capecitabine Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Capecitabine Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Capecitabine Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Capecitabine Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Teva Pharmaceutical Industries Ltd.(Israel)
11.2.2. F. Hoffmann-La Roche Ltd. (Switzerland)
11.2.3. Mylan N.V. (U.S.)
11.2.4. Pfizer Inc. (US.)
11.2.5. Sanofi (France)
11.2.6. Bayer AG (Germany)
11.2.7. Lilly (US.)
11.2.8. Sun Pharmaceutical Industries Ltd. (India)
11.2.9. GSK plc (UK.)
11.2.10. Novartis AG (Switzerland)
11.2.11. Merck & Co., Inc. (US.)
11.2.12. Alkem Labs Ltd (India)
11.2.13. Aurobindo Pharma (India)
11.2.14. Lupin (India)
11.2.15. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
